Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 55.51B | 52.98B | 46.79B | 37.69B | 31.66B |
Gross Profit | 17.40B | 14.99B | 11.52B | 10.44B | 9.85B |
EBITDA | 7.65B | 5.90B | 3.12B | 2.78B | 2.79B |
Net Income | 4.32B | 3.01B | 898.00M | 273.00M | 978.00M |
Balance Sheet | |||||
Total Assets | 63.40B | 62.17B | 56.28B | 51.09B | 48.37B |
Cash, Cash Equivalents and Short-Term Investments | 12.38B | 12.34B | 8.03B | 7.26B | 8.08B |
Total Debt | 5.95B | 6.59B | 7.57B | 6.29B | 6.93B |
Total Liabilities | 18.43B | 19.54B | 19.30B | 17.22B | 16.20B |
Stockholders Equity | 43.43B | 40.20B | 34.65B | 31.44B | 30.13B |
Cash Flow | |||||
Free Cash Flow | 4.04B | 3.60B | -382.00M | -119.00M | 852.00M |
Operating Cash Flow | 4.80B | 4.30B | 174.00M | 294.00M | 1.57B |
Investing Cash Flow | -1.14B | 413.00M | 59.00M | -733.00M | -555.00M |
Financing Cash Flow | -2.41B | -1.60B | -83.00M | -1.42B | 208.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥159.48B | 13.47 | 1.53% | 12.70% | 34.96% | ||
78 Outperform | ¥184.27B | 13.08 | 2.40% | 3.26% | -13.75% | ||
78 Outperform | ¥20.65B | 8.19 | 4.35% | 6.41% | -3.59% | ||
77 Outperform | ¥29.55B | 10.78 | 0.15% | 9.61% | 53.78% | ||
76 Outperform | ¥29.87B | 6.01 | 4.46% | 3.47% | 33.32% | ||
69 Neutral | ¥4.67B | 32.55 | 1.23% | -5.30% | -6.24% | ||
58 Neutral | HK$18.72B | 4.84 | -7.29% | 3.76% | -4.22% | -42.85% |
Yushiro Chemical Industry Co., Ltd. reported a notable increase in its financial performance for the nine months ending December 31, 2024, with a 5.9% rise in net sales and a significant boost in operating profit by 34.6% compared to the previous year. The company forecasts continued growth with expected increases in net sales and profits for the fiscal year ending March 31, 2025, indicating a positive outlook for stakeholders and reinforcing its industry positioning.